What Is The Current and Historic Market Size Analysis Of The Allergic Rhinitis Market?
The allergic rhinitis market has seen considerable growth due to a variety of factors.
• In recent years, there has been a consistent increase in the size of the allergic rhinitis market. It is projected to expand from $15.22 billion in 2024 to $15.74 billion in 2025, signifying a compound annual growth rate (CAGR) of 3.4%.
The expansion during the historic period can be traced back to several factors such as exposure to allergens, changes in the environment, heightened public awareness, escalating levels of pollution, developments in research related to allergic rhinitis, and an increase in disposable incomes.
What are the Market Size and Expected Growth Rates for the Allergic Rhinitis Market?
The allergic rhinitis market is expected to maintain its strong growth trajectory in upcoming years.
• The market for allergic rhinitis is predicted to expand consistently in the years ahead, with projections estimating a size of $18.49 billion by 2029, indicating growth at a compound annual growth rate (CAGR) of 4.1%.
Factors contributing to the anticipated growth within the forecast period encompass a rising demand for proactive treatment options, an aging demographic, urbanization, and healthcare expenditure. Some prominent tendencies expected in the forecast period include the use of biologics and monoclonal antibodies, advancements in digital healthcare, strategies to evade allergens, treatment of pediatric allergic rhinitis, and allergen identification technologies.
Which Key Drivers Are Propelling The Allergic Rhinitis Market's Growth?
Elevated levels of atmospheric pollution and changes in global climate are predicted to stimulate the expansion of the allergic rhinitis market. Air pollution, as defined by the harmful substances present in our atmosphere, poses detriments to our health, environmental conditions, and overall air quality. In a similar vein, climate change denotes lasting changes in global weather patterns - including temperature, rainfall and other climatic elements. The significant role of air pollution as an environmental element exacerbating the incidence and severity of allergic rhinitis underscores the intricate link between air quality and respiratory health. As recorded by the United States Environmental Protection Agency in August 2024, in 2023, an alarming 66 million tons of pollutants were discharged into the U.S. atmosphere. Consequently, heightened levels of air pollution and climate change constitute a significant driver for the allergic rhinitis market. The boost in corticosteroid treatments dedicated to managing allergic rhinitis is anticipated to quicken the growth rate of the allergic rhinitis market. Steroid treatments, or corticosteroid treatments, entail the application of medication simply known as corticosteroids or steroids. Their prevalent use in treating allergic rhinitis is due to their efficacy in alleviating inflammation within the nasal passages and in ameliorating symptoms associated with the disorder. For instance, according to the American Society for Clinical Pharmacology and Therapeutics in September 2023, the average use of oral corticosteroids measured at 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, demonstrating an annual increment from 0.1% to 0.17%. Majority of these prescriptions were featured in short bursts, spanning 1-29 days, generally prescribed to healthy adults with self-limiting conditions like respiratory infections. Therefore, the increased prevalence of corticosteroid treatments for allergic rhinitis is instrumental in driving the growth of the allergic rhinitis market.
What Are The Key Segments Within The Global Allergic Rhinitis Market?
The allergic rhinitis market covered in this report is segmented –
1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis
2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments
3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count
4) By Route Of Administration: Oral, Nasal, Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores
Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens
Pre-Book The Allergic Rhinitis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Allergic Rhinitis Market?
Key players in the allergic rhinitis market are introducing inventive medications to maintain their market leadership. For instance, Hikma Pharmaceuticals PLC, a UK-originating pharmaceutical corporation, and Glenmark Specialty S.A., hailing from Switzerland, achieved the United States Food and Drug Administration (FDA), a US federal agency’s, approval for their product Ryaltris in August 2022. This marks the debut of the first stable-dose combination drug used for the treatment of nasal and eye-related symptoms of seasonal allergic rhinitis. Designed as a convenient nasal spray, it is suitable for adult and pediatric patients aged 12 and above. Remarkably, the alleviation of nasal symptoms commences within a mere 15 minutes of the first dose.
Who Are the Key Players In The Allergic Rhinitis Market?
Major companies operating in the allergic rhinitis market are:
• Merck and Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Limited
• Endo Pharmaceuticals Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited
• Glenmark Pharma Ltd.
• Almirall S.A.
• Kyowa Kirin Co. Ltd.
• Hanmi Pharmaceutical Co. Ltd.
• Akorn Inc.
What Are The Regional Insights Into The Allergic Rhinitis Market?
North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
